Biotronik gets FDA approval for Pulsar-18 T3 peripheral self-expanding stent system
The Pulsar-18 T3 stent system is indicated for improving luminal diameter in patients with lesions in the superficial…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Jul 22
The Pulsar-18 T3 stent system is indicated for improving luminal diameter in patients with lesions in the superficial…
27 Jul 22
Virtuos gives the hospital considerable logistical and financial benefits along with enhanced shipping, storage, and operating room efficiency
27 Jul 22
The RADIANCE II is a randomised, sham-controlled clinical trial of the ReCor Paradise uRDN System for the treatment…
27 Jul 22
Our newest osmometer delivers the automation and data management capabilities modern clinical labs require to free up tech…
26 Jul 22
The IC-8 Apthera IOL, with an extended depth of focus, leverages the company’s small aperture technology to filter…
26 Jul 22
The funds will help Cleerly increase its headcount and widen its market reach to increase patient and physician…
26 Jul 22
The EUA authorisation will allow the firm to expand its testing capabilities to provide more testing services to…
26 Jul 22
VERIstic is said to be suitable for use at-home and clinician-assisted collection methods enabled by a simple finger…
26 Jul 22
Berkshire Biomedical Corporation is a privately held medical device company. Berkshire is developing drug dispensing technologies designed to…
26 Jul 22
As part of its commitment to accelerating infectious disease diagnostics, HealthTrackRx will deliver next-day monkeypox results to physicians…